Abstract: A three dimensional circuit system includes first and second integrated circuit (IC) dies. The first IC die includes programmable logic circuits arranged in sectors and first programmable interconnection circuits having first router circuits. The second IC die includes non-programmable circuits arranged in regions and second programmable interconnection circuits having second router circuits. Each of the regions in the second IC die is vertically aligned with at least one of the sectors in the first IC die. Each of the second router circuits is coupled to one of the first router circuits through a vertical die-to-die connection. The first and second programmable interconnection circuits are programmable to route signals between the programmable logic circuits and the non-programmable circuits through the first and second router circuits. The circuit system may include additional IC dies. The first and second IC dies and any additional IC dies are coupled in a vertically stacked configuration.

Abstract: A cache subsystem is disclosed. The cache subsystem includes a cache configured to store information in cache lines arranged in a plurality of ways. A requestor circuit generates a request to access a particular cache line in the cache. A prediction circuit is configured to generate a prediction of which of the ways includes the particular cache line. A comparison circuit verifies the prediction by comparing a particular address tag associated with the particular cache line to a cache tag corresponding to a predicted one of the ways. Responsive to determining that the prediction was correct, a confirmation indication is stored indicating the correct prediction. For a subsequent request for the particular cache line, the cache is configured to forego a verification of the prediction that the particular cache line is included in the one of the ways based on the confirmation indication.

Abstract: A system for controlling an operative parameter of a harvesting header of an agricultural harvesting machine comprises a first sensing arrangement for sensing a property of a field in front of the header in a contact-less manner, a second sensing arrangement for providing a signal suited to derive a value of an adjustable work parameter of the header, an actuator for adjusting the work parameter, and a control unit for determining a control signal for the actuator based on the signal from the first sensing arrangement and on the signal from the second sensing arrangement. The second sensing arrangement is arranged to detect the position of a reference point, which indicates the work parameter, in a contact-less manner, and that the first sensing arrangement and the second sensing arrangement are relatively fixed.

Abstract: In one embodiment, a method includes receiving a stored copy request indicating data and including a request identifier, scheduling publication of the data to an object store, and sending a subscription request indicating the data and the request identifier to the object store. In another embodiment, a method includes receiving a publication request indicating data to be copied, wherein the publication request is a recording request indicating a channel and a timespan, receiving one or more subscription requests for the data, receiving the data, and generating a copy of the data for each subscription request.

Abstract: The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III, formula IV, formula V, formula VI, formula VII, formula VIII, formula IX or Formula X and, the methods for the treatment of fungal infections may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of fungal infections.

Abstract: An elevator provides for lifting and disconnecting an electronic device from a chassis circuit board and the subsequent removal of the device from a chassis slot. A sliding element between the device and the slot includes tracks within which travel followers associated with the electronic device. Motion in a first direction the tracks causes the tracks to move with respect to the followers, raising the device away from the circuit board. In a fully raised position, the device is disconnected and may be removed from the slot. Motion in the opposite direction causes the relative motion between the track and follower to lower the device toward the circuit board. In a fully seated position, the device is connected to the circuit board.

Abstract: The disclosure relates to test kits and methods for detecting the presence of multiple human papilloma vims polynucleotides in a biological sample.

Abstract: Methods and systems are provided for assisting operation of a vehicle using speech recognition. One method involves analyzing a transcription of an audio communication with respect to the vehicle to characterize a nonstandard pattern within the transcription of the audio communication, obtaining a ground truth for the transcription of the audio communication, determining one or more performance metrics associated with the nonstandard pattern within the transcription based on a relationship between the transcription of the audio communication and the ground truth for the transcription, updating a speech recognition vocabulary for the vehicle to include the nonstandard pattern based at least in part on the one or more performance metrics and determining an updated speech recognition model for the vehicle using the updated speech recognition vocabulary and the audio communication.

Abstract: The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III, formula IV, formula V, formula VI, formula VII, formula VIII, formula IX or Formula X and, the methods for the treatment of fungal infections may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of fungal infections.

Abstract: Systems and methods for providing immersive avionics training include controlling a virtual or augmented reality device to present, to a user, a virtual or augmented reality simulation of a user interface of an avionics system including a simulation of a display of the avionics system. The method further includes detecting a user action based on a point of gaze and touch inputs of the user indicative of a user command to use a functionality of the avionics system. The user action is a physical interaction with a control panel apparatus representing an input device of the user interface of the avionics system. The method also includes simulating the use of the functionality in accordance with the user command to generate output data and controlling the virtual or augmented reality device to simulate display of the output data in the simulation of the display of the avionics system.

Abstract: Techniques for context aware access control with weapons detection are provided. An indication of an identity of a person is received at an access control system. The indication of the identity of the person includes a confidence level of the identification. An indication of a threat level of the person is received at a threat detection system. The threat level including a confidence level of the threat level. At least one of an identification threshold or a threat level threshold is modified based on the threat level confidence level or the confidence level of the identification. At least one of allowing access, allowing access with an alarm indication, or denying access to the person is based in part on the modified identification threshold or threat level threshold.

Abstract: Techniques are described herein for using special session identifiers to defer additional authentication steps (AAS) for at least some restricted application actions. A client session is associated with a special session identifier that is mapped to an authentication tier (AT) achieved for the session based on the satisfied authentication steps. Web servers that are enabled for AAS deferral include context information, which identifies a requested action, with session verification requests to an authentication service. The authentication service determines that AAS is required to perform an action when (a) the AT associated with the action is a higher-security tier than the AT associated with the session, or (b) the session is associated with an AT that is lower than the highest-security AT and there is no context information accompanying the request for session validation, in which case the authentication service assumes that the highest-security AT is required to perform the request.

Abstract: A method, system and computer program product for emulating depth data of a three-dimensional camera device is disclosed. The method includes concurrently operating the radar device and the 3D camera device to generate training radar data and training depth data respectively. Each of the radar device and the 3D camera device has a respective field of view. The field of view of the radar device overlaps the field of view of the 3D camera device. The method also includes inputting the training radar and depth data to the neural network. The method also includes employing the training radar and depth data to train the neural network. Once trained, the neural network is configured to receive real radar data as input and to output substitute depth data.

Abstract: The present disclosure is drawn to compositions and methods for treating CNS disorders. In one embodiment, an oral pharmaceutical composition can comprise a therapeutically effective amount of pregn-4-ene-3,20-dione; and a pharmaceutically acceptable carrier that provides formation of either 3?-OH-5?-pregnan-20-one, or 3?-OH-5?-pregnan-20-one, or both in an amount sufficient to treat a CNS disorder when orally administered to a subject. In another embodiment, a method of treating a CNS disorder can comprise orally administering to a subject, a therapeutically effective amount of pregn-4-ene-3,20-dione that provides an amount of GABA receptor binding pregn-4-ene-3,20-dione metabolites that is sufficient to treat the CNS disorder.

Abstract: Efficient tagging of content items using content embeddings are provided. In one technique, multiple content items are stored a content embedding for content item is stored. Entity names are also stored along with an entity name embedding for each entity name. For each content item, (1) multiple content embeddings that are associated with the content item are identified; (2) a subset of the entity names is identified; and (3) for each entity name in the subset, (i) an embedding of the entity name is identified, (ii) similarity measures are generated based on the entity name embedding and the multiple content embeddings, (iii), a distribution of the similarity measures is generated, (iv) feature values are generated based on the distribution, (v) the feature values are input into a machine-learned classifier, and (vi) based on output from the classifier, it is determined whether to associate the entity name with the content item.

Abstract: Disclosed are bioavailable solid state (17-?)-3-Oxoandrost-4-en-17-yl dodecanoate compositions and methods of use in administration to mammals in need of thereof. The (17-?)-3-Oxoandrost-4-en-17-yl dodecanoate is preferably provided in a solid state crystalline form having a plurality of peaks corresponding to the peaks shown in FIG. 2, a plurality of crystallites ranging in size from about 40 nm to about 60 nm based as identified via powder x-ray diffraction spectra, and a melting point in the range of about 51° C. to about 63° C. The compositions may be provided in oral or injectable administration form for the treatment of conditions such as in need of testosterone therapy.

Abstract: A point-of-sale terminal is provided. The point-of-sale terminal includes a processor and a memory configured to store transaction data therein. The point-of-sale terminal further includes a network interface configured to connect to a computing network. The network interface is further configured to receive, from the network, a message comprising blockchain information. The point-of-sale terminal is configured to store the transaction data in a blockchain ledger.

Abstract: The embodiments provide a bioengineered artificial functional liver which is connected to a patient suffering from acute liver failure and would functional like an ectopic liver. The device uses the cells derived from the patient's own body thereby nullifying the chances of self/non-self-recognition and related immune activation and rejection. The extracted liver cells are grown on a customized 3D matrix called as 3D cell cartridge and these cell cartridges individually function as miniature liver assemblies. Multiple such assemblies when working in parallel would rescue the condition of liver failure. A microfluidic chamber is built with the similar network as found in the liver and the chamber has flow circuits for plasma/de-cellularised blood and the flow circuits are lined by a coculture of hepatocytes, endothelial cells and fibroblasts. The array of cells in the chamber serve as a miniature liver and multiple such arrays will be stacked to achieve a significant hepatic function.

Abstract: A port is to couple to another die over a die-to-die (D2D) link and includes a die-tio-die (D2D) adapter to determine, from a set of registers, a set of capabilities of the D2D adapter to advertise in a negotiation with a link partner D2D adapter, where the D2D adapter is on a die and the link partner D2D adapter is located on a remote link partner die. A first capabilities advertisement message is sent to the link partner D2D adapter to advertise the set of capabilities to the link partner D2D adapter. A second capabilities advertisement message is received from the link partner D2D adapter, wherein the second capabilities advertisement message identifies a set of capabilities of the link partner D2D adapter. A final configuration of a D2D link is determined to couple the die to the link partner die.

Abstract: A circuit system includes a processing integrated circuit die comprising a first die-to-die interface circuit and a memory interface circuit. The circuit system also includes a second integrated circuit die comprising a second die-to-die interface circuit and a compute circuit that performs computations for the processing integrated circuit die. The first and the second die-to-die interface circuits are coupled together. The compute circuit is coupled to exchange information with the memory interface circuit through the first and the second die-to-die interface circuits.